Pradofloxacin

Last updated

Pradofloxacin
Pradofloxacin.svg
Clinical data
Trade names Veraflox, Pradalex
License data
Routes of
administration 		By mouth, intramuscular, subcutaneous
ATCvet code
Legal status
Legal status
Identifiers
  • 8-Cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-(4.3.0)nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard 100.169.611 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C21H21FN4O3
Molar mass 396.422 g·mol−1
3D model (JSmol)
  • O=C(O)C1=CN(C2CC2)c3c(C1=O)cc(F)c(c3C#N)N4C[C@H]5NCCC[C@H]5C4
  • InChI=1S/C21H21FN4O3/c22-16-6-13-18(26(12-3-4-12)9-15(20(13)27)21(28)29)14(7-23)19(16)25-8-11-2-1-5-24-17(11)10-25/h6,9,11-12,17,24H,1-5,8,10H2,(H,28,29)/t11-,17+/m0/s1 X mark.svgN
  • Key:LZLXHGFNOWILIY-APPDUMDISA-N X mark.svgN
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Pradofloxacin, sold under the brand name Veraflox among others, is a third-generation enhanced spectrum veterinary antibiotic of the fluoroquinolone class. [5] It was developed by Elanco Animal Health GmbH and received approval from the European Commission in April 2011, for prescription-only use in veterinary medicine for the treatment of bacterial infections in dogs and cats. [6]

Contents

Medical uses

Dogs

In the European Union, pradofloxacin is indicated for the treatment of: [7]

Cats

In the European Union, pradofloxacin is indicated for the treatment of: [7]

Cattle and swine

In the United States, pradofloxacin is indicated for certain respiratory diseases in cattle and swine. [5] It is approved for certain ages and classes of cattle for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica , Pasteurella multocida , Histophilus somni , and Mycoplasma bovis . [5] It may only be prescribed for cattle intended for slaughter and cattle intended for breeding that are less than one year of age; it is not for use in cattle intended for breeding one year of age and older, beef calves less than two months of age, dairy calves, and veal calves. [5] It is approved for use in swine for the treatment of swine respiratory disease (SRD) associated with Bordetella bronchiseptica , Glaesserella (Haemophilus) parasuis , Pasteurella multocida , Streptococcus suis , and Mycoplasma hyopneumoniae . [5] It may only be prescribed for weaned swine intended for slaughter; it is not for use in swine intended for breeding or nursing piglets. [5]

Mechanism of action

The primary mode of action of fluoroquinolones involves interaction with enzymes essential for major DNA functions such as replication, transcription and recombination. The primary targets for pradofloxacin are the bacterial DNA gyrase and topoisomerase IV enzymes. Reversible association between pradofloxacin and DNA gyrase or DNA topoisomerase IV in the target bacteria results in inhibition of these enzymes and rapid death of the bacterial cell. The rapidity and extent of bacterial killing are directly proportional to the drug concentration. [7]

As a result, pradofloxacin is active against a wide range of Gram-positive and Gram-negative bacteria including anaerobic bacteria. [7]

History

Pradofloxacin was first discovered by chemists at Bayer in 1994 and patented in 1998. The name pradofloxacin was issued in December 2000 by the World Health Organization. Following submission for marketing authorisation to the European Medicines Agency (EMA) in 2004, the application was refused in 2006, [9] prompting further studies.

Having reviewed the additional studies, the EMA Committee for Medicinal Products for Veterinary Use (CVMP) recommended granting marketing authorisation of pradofloxacin by consensus in February 2011. [10] Marketing authorisation of pradofloxacin was granted by the European Commission in April 2011. [6]

Related Research Articles

<span class="mw-page-title-main">Ciprofloxacin</span> Fluoroquinolone antibiotic

Ciprofloxacin is a fluoroquinolone antibiotic used to treat a number of bacterial infections. This includes bone and joint infections, intra-abdominal infections, certain types of infectious diarrhea, respiratory tract infections, skin infections, typhoid fever, and urinary tract infections, among others. For some infections it is used in addition to other antibiotics. It can be taken by mouth, as eye drops, as ear drops, or intravenously.

<span class="mw-page-title-main">Levofloxacin</span> Antibiotic

Levofloxacin, sold under the brand name Levaquin among others, is an antibiotic medication. It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, H. pylori, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. Along with other antibiotics it may be used to treat tuberculosis, meningitis, or pelvic inflammatory disease. Use is generally recommended only when other options are not available. It is available by mouth, intravenously, and in eye drop form.

<span class="mw-page-title-main">Ofloxacin</span> Antibiotic to treat bacterial infections

Ofloxacin is a quinolone antibiotic useful for the treatment of a number of bacterial infections. When taken by mouth or injection into a vein, these include pneumonia, cellulitis, urinary tract infections, prostatitis, plague, and certain types of infectious diarrhea. Other uses, along with other medications, include treating multidrug resistant tuberculosis. An eye drop may be used for a superficial bacterial infection of the eye and an ear drop may be used for otitis media when a hole in the ear drum is present.

<span class="mw-page-title-main">Nalidixic acid</span> First of the synthetic quinolone antibiotics

Nalidixic acid is the first of the synthetic quinolone antibiotics.

<span class="mw-page-title-main">Norfloxacin</span> Chemical compound, antibiotic

Norfloxacin, sold under the brand name Noroxin among others, is an antibiotic that belongs to the class of fluoroquinolone antibiotics. It is used to treat urinary tract infections, gynecological infections, inflammation of the prostate gland, gonorrhea and bladder infection. Eye drops were approved for use in children older than one year of age.

<span class="mw-page-title-main">Trovafloxacin</span> Antibiotic

Trovafloxacin is a broad spectrum antibiotic that inhibits the uncoiling of supercoiled DNA in various bacteria by blocking the activity of DNA gyrase and topoisomerase IV. It was withdrawn from the market due to the risk of hepatotoxicity. It had better Gram-positive bacterial coverage but less Gram-negative coverage than the previous fluoroquinolones.

<span class="mw-page-title-main">Moxifloxacin</span> Antibiotic

Moxifloxacin is an antibiotic, used to treat bacterial infections, including pneumonia, conjunctivitis, endocarditis, tuberculosis, and sinusitis. It can be given by mouth, by injection into a vein, and as an eye drop.

<span class="mw-page-title-main">Marbofloxacin</span> Chemical compound

Marbofloxacin is a carboxylic acid derivative third generation fluoroquinolone antibiotic. It is used in veterinary medicine under the brand names Marbocyl, Forcyl, Marbo vet and Zeniquin. A formulation of marbofloxacin combined with clotrimazole and dexamethasone is available under the name Aurizon.

<i>Pasteurella multocida</i> Species of bacterium

Pasteurella multocida is a Gram-negative, nonmotile, penicillin-sensitive coccobacillus of the family Pasteurellaceae. Strains of the species are currently classified into five serogroups based on capsular composition and 16 somatic serovars (1–16). P. multocida is the cause of a range of diseases in mammals and birds, including fowl cholera in poultry, atrophic rhinitis in pigs, and bovine hemorrhagic septicemia in cattle and buffalo. It can also cause a zoonotic infection in humans, which typically is a result of bites or scratches from domestic pets. Many mammals and birds harbor it as part of their normal respiratory microbiota.

<span class="mw-page-title-main">Cefquinome</span> Chemical compound

Cefquinome is a fourth-generation cephalosporin with pharmacological and antibacterial properties valuable in the treatment of coliform mastitis and other infections. It is only used in veterinary applications.

<span class="mw-page-title-main">Flumequine</span> Chemical compound

Flumequine is a synthetic fluoroquinolone antibiotic used to treat bacterial infections. It is a first-generation fluoroquinolone antibacterial that has been removed from clinical use and is no longer being marketed. The marketing authorization of flumequine has been suspended throughout the EU. It kills bacteria by interfering with the enzymes that cause DNA to unwind and duplicate. Flumequine was used in veterinarian medicine for the treatment of enteric infections, as well as to treat cattle, swine, chickens, and fish, but only in a limited number of countries. It was occasionally used in France to treat urinary tract infections under the trade name Apurone. However this was a limited indication because only minimal serum levels were achieved.

<span class="mw-page-title-main">Tulathromycin</span> Cattle and pig antibiotic

Tulathromycin, sold under the brand name Draxxin among others, is a macrolide antibiotic used to treat bovine respiratory disease in cattle and swine respiratory disease in pigs.

<span class="mw-page-title-main">Difloxacin</span> Chemical compound

Difloxacin (INN), marketed under the trade name Dicural, is a second-generation, synthetic fluoroquinolone antibiotic used in veterinary medicine. It has broad-spectrum, concentration dependent, bactericidal activity; however, its efficacy is not as good as enrofloxacin or pradofloxacin.

<span class="mw-page-title-main">Delafloxacin</span> Chemical compound

Delafloxacin sold under the brand name Baxdela among others, is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections.

Haemorrhagic septicaemia (HS) is one of the most economically important pasteurelloses. Haemorrhagic septicaemia in cattle and buffaloes was previously known to be associated with one of two serotypes of P. multocida: Asian B:2 and African E:2 according to the Carter-Heddleston system, or 6:B and 6:E using the Namioka-Carter system.

<span class="mw-page-title-main">Quinolone antibiotic</span> Class of antibacterial drugs, subgroup of quinolones

Quinolone antibiotics constitute a large group of broad-spectrum bacteriocidals that share a bicyclic core structure related to the substance 4-quinolone. They are used in human and veterinary medicine to treat bacterial infections, as well as in animal husbandry, specifically poultry production.

Pasteurella canis is a Gram-negative, nonmotile, penicillin-sensitive coccobacillus of the family Pasteurellaceae. Bacteria from this family cause zoonotic infections in humans, which manifest themselves as skin or soft-tissue infections after an animal bite. It has been known to cause serious disease in immunocompromised patients.

Bovine respiratory disease (BRD) is the most common and costly disease affecting beef cattle in the world. It is a complex, bacterial or viral infection that causes pneumonia in calves which can be fatal. The infection is usually a sum of three codependent factors: stress, an underlying viral infection, and a new bacterial infection. The diagnosis of the disease is complex since there are multiple possible causes.

Bovine respiratory syncytial virus (BRSV) is pneumovirus closely related to human respiratory syncytial virus (RSV) that is a common cause of respiratory disease in cattle, particularly calves. It is a negative-sense, single-stranded RNA virus that replicates in the cytoplasm of the cell. Similarly to other single-stranded RNA viruses, the genome of BRSV has a high mutation rate, which results in great antigenetic variation. Thus, BRSV can be split into four different subgroups based on antigen expression.

<span class="mw-page-title-main">Tildipirosin</span> Medication

Tildipirosin, sold under the brand name Zuprevo is an antibiotic used in pigs and cattle.

References

  1. ↑ "Veraflox Product information". Health Canada . 19 May 2022. Retrieved 12 April 2024.
  2. ↑ "Veraflox- pradofloxacin suspension". DailyMed. 14 October 2022. Retrieved 12 April 2024.
  3. ↑ https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/15250
  4. ↑ "Veraflox EPAR". European Medicines Agency. 12 April 2011. Retrieved 12 April 2024.
  5. 1 2 3 4 5 6 "FDA Approves New Antimicrobial Drug for Cattle and Swine". U.S. Food and Drug Administration (FDA). 9 April 2024. Retrieved 12 April 2024.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  6. 1 2 "Veraflox Product information". Union Register of veterinary medicinal products. Retrieved 20 June 2012.
  7. 1 2 3 4 "Veraflox Summary of Product Characteristics" (PDF). European Medicines Agency. April 2011.
  8. ↑ "NOAH Compendium of Animal Medicines: Veraflox Tablets - Dosage and administration". Archived from the original on 28 April 2015. Retrieved 29 June 2015.
  9. ↑ "European Medicines Agency - Find medicine - Veraflox". European Medicines Agency. Retrieved 20 June 2012.
  10. ↑ "European Medicines Agency - Find medicine - Veraflox". European Medicines Agency. Retrieved 20 June 2012.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.